Eiko Lifesciences Ltd
EIKOEiko Lifesciences Ltd
EIKO
Price Chart
Scorecard
Performance
LowHasn't fared well - amongst the low performers
Valuation
HighSeems to be overvalued vs the market average
Growth
LowLagging behind the market in financials growth
Profitability
AvgAverage profitability - not good, not bad
Entry point
AvgThe stock is not in the overbought zone
Red flags
LowNo red flag found
How to use scorecard? Learn more
Key Metrics
| No LabelNo Label | PB RatioPB Ratio | Dividend YieldDiv. Yield |
|---|---|---|
| 132.29 | 1.64 | — |
| Sector PESector PE | Sector PBSector PB | Sector Div YldSctr Div Yld |
|---|---|---|
| 0 | 0 | — |
Forecast & Ratings
Detailed Forecast Price
Price Upside
Earnings
Earnings Growth
Revenue
Rev. Growth
Company Profile
Narendra Investments Delhi is engaged in investment activities
Peers
Compare with peersMotilal Oswal Financial Services Ltd
Aditya Birla Capital Ltd
Cholamandalam Financial Holdings Ltd
Piramal Enterprises Ltd
Nuvama Wealth Management Ltd
Get more out of Tickertape, Go Pro!
Customise key metrics, see detailed forecasts, download stock data and more
Forecasts
Price
Revenue
Earnings
Price Forecast
Hmm, looks like data is unavailable here. Please come back after some timeRevenue Forecast
Hmm, looks like data is unavailable here. Please come back after some timeEarnings Per Share Forecast
Hmm, looks like data is unavailable here. Please come back after some timeIncome
Balance Sheet
Cash Flow
Income Statement
| Financial Year | FY 2016 | FY 2017 | FY 2018 | FY 2019 | FY 2020 | FY 2021 | FY 2022 | FY 2023 | FY 2024 | TTM | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | 0.58 | 0.40 | 0.51 | 0.39 | 0.43 | 12.45 | 26.08 | 19.17 | 28.11 | 20.76 | ||||||||||
Raw Materials | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 10.67 | 25.05 | 13.66 | 27.20 | 19.40 | ||||||||||
| Power & Fuel Cost | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.02 | 0.10 | 0.04 | 0.07 | |||||||||||
| Employee Cost | 0.10 | 0.06 | 0.07 | 0.02 | 0.07 | 0.12 | 0.23 | 0.23 | 0.16 | |||||||||||
| Selling & Administrative Expenses | 0.36 | 0.08 | 0.11 | 0.17 | 0.10 | 0.20 | 0.45 | 0.42 | 0.47 | |||||||||||
| Operating & Other expenses | 0.00 | 0.00 | -0.00 | 0.00 | 0.00 | 0.47 | -1.73 | 3.01 | -1.59 | |||||||||||
EBITDA | 0.12 | 0.26 | 0.33 | 0.20 | 0.26 | 0.97 | 1.98 | 1.81 | 1.80 | 1.36 | ||||||||||
| Depreciation/Amortization | 0.00 | 0.02 | 0.06 | 0.06 | 0.06 | 0.06 | 0.56 | 0.63 | 0.66 | 0.41 | ||||||||||
| PBIT | 0.12 | 0.24 | 0.27 | 0.14 | 0.20 | 0.91 | 1.42 | 1.18 | 1.14 | 0.95 | ||||||||||
| Interest & Other Items | 0.00 | 0.02 | 0.05 | 0.03 | 0.07 | 0.09 | 0.48 | 0.16 | 0.15 | 0.18 | ||||||||||
| PBT | 0.12 | 0.22 | 0.22 | 0.11 | 0.13 | 0.82 | 0.94 | 1.02 | 0.99 | 0.77 | ||||||||||
| Taxes & Other Items | 0.03 | 0.06 | 0.03 | 0.03 | 0.00 | 0.22 | 0.23 | 0.26 | 0.23 | 0.14 | ||||||||||
| Net Income | 0.09 | 0.16 | 0.19 | 0.08 | 0.13 | 0.60 | 0.71 | 0.76 | 0.76 | 0.63 | ||||||||||
| EPS | 0.26 | 0.46 | 0.48 | 0.18 | 0.29 | 1.36 | 1.01 | 0.79 | 0.65 | 0.45 | ||||||||||
| DPS | 0.00 | 0.22 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | ||||||||||
| Payout ratio | 0.00 | 0.47 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Company Updates
Annual report
PDFAnnual report
PDFAnnual report
PDFAnnual report
PDFAnnual report
PDFAnnual report
PDFPeers & Comparison
-Diversified Financials
Valuation
Technical
Forecast
Compare valuation on Screener| Stock | PE RatioPE Ratio | PB RatioPB Ratio | Div. YieldDividend Yield |
|---|---|---|---|
| Eiko Lifesciences Ltd | 109.66 | 1.64 | — |
| Motilal Oswal Financial Services Ltd | 23.97 | 6.67 | 0.36% |
| Aditya Birla Capital Ltd | 15.64 | 1.82 | — |
| Cholamandalam Financial Holdings Ltd | 16.25 | 1.30 | 0.04% |
Price Comparison
Compare EIKO with any stock or ETFShareholdings
Promoter Holdings Trend
Increased Total Promoter Holding
In last 6 months, promoter holding in the company has increased by 6.87%
Low Pledged Promoter Holding
Pledged promoter holdings is insignificant
Institutional Holdings Trend
Total Retail Holding
In last 3 months, retail holding in the company has almost stayed constant
Foreign Institutional Holding
In last 3 months, foreign institutional holding of the company has almost stayed constant
Shareholding Pattern
Mar 2024
Jun 2024
Sep 2024
Nov 2024
Shareholding History
smallcases
Looks like this stock is not in any smallcase yet.
Events
Dividend Trend
No Dividends
EIKO has not given any dividends in last 5 years
Dividends
Corp. Actions
Announcements
Legal Orders
Upcoming Dividends
No upcoming dividends are available
Past Dividends
Cash Dividend
Ex DateEx DateSep 20, 2017
Dividend/Share
₹0.25
Ex DateEx Date
Sep 20, 2017
Eiko Lifesciences will hold a meeting of the Board of Directors of the Company on 25 November 2024Powered by Capital Market - Live
Net profit of Eiko Lifesciences rose 75.00% to Rs 0.21 crore in the quarter ended September 2024 as against Rs 0.12 crore during the previous quarter ended September 2023. Sales rose 20.75% to Rs 7.74 crore in the quarter ended September 2024 as against Rs 6.41 crore during the previous quarter ended September 2023. ParticularsQuarter EndedSep. 2024Sep. 2023% Var. Sales7.746.41 21 OPM %4.655.46 - PBDT0.450.32 41 PBT0.290.16 81 NP0.210.12 75 Powered by Capital Market - Live
Eiko Lifesciences will hold a meeting of the Board of Directors of the Company on 19 October 2024.Powered by Capital Market - Live
Eiko Lifesciences announced that the 47th Annual General Meeting (AGM) of the company will be held on 28 September 2024.Powered by Capital Market - Live
Net profit of Eiko Lifesciences rose 337.50% to Rs 0.35 crore in the quarter ended June 2024 as against Rs 0.08 crore during the previous quarter ended June 2023. Sales rose 65.13% to Rs 10.75 crore in the quarter ended June 2024 as against Rs 6.51 crore during the previous quarter ended June 2023. ParticularsQuarter EndedJun. 2024Jun. 2023% Var. Sales10.756.51 65 OPM %3.814.15 - PBDT0.640.27 137 PBT0.470.11 327 NP0.350.08 338 Powered by Capital Market - Live
Eiko Lifesciences will hold a meeting of the Board of Directors of the Company on 13 August 2024.Powered by Capital Market - Live
Higher than Industry Revenue Growth
Over the last 5 years, revenue has grown at a yearly rate of 135.27%, vs industry avg of 11.37%
Increasing Market Share
Over the last 5 years, market share increased from 0% to 0.02%
Higher than Industry Net Income
Over the last 5 years, net income has grown at a yearly rate of 56.87%, vs industry avg of 24.22%